Author

Barbara Nitsche

Observed name: B. Nitsche

Institution: Otto-von-Guericke-Universität Magdeburg

Observed institutions: University of Würzburg, Universitätsklinikum Würzburg, Otto-von-Guericke-Universität Magdeburg

OpenAlex ID: A5038693145

The tyrosine kinase inhibitor imatinib fails to inhibit pancreatic cancer progression

2006 · Jie Chen, Christoph Röcken, et al. · Cancer Letters · 39

Implications of growth factor alterations in the treatment of pancreatic cancer.

2003 · Márk Juhász, Barbara Nitsche, et al. · Molecular Cancer · 16

Rhizopus oligosporus as a Cause of Mucormycosis in Man: Rhizopus oligospovus als Mucormykose‐Erreger beim Menschen

1989 · Kathrin Tintelnot, Barbara Nitsche · Mycoses · 11

Non-neoplastic lesions of female virgin Han:NMRI mice, incidence and influence of food restriction throughout life span. I: Thyroid

1985 · Sabine Rehm, Barbara Nitsche, et al. · Laboratory Animals · 11

Incidence and morphology of spontaneous thyroid tumours in different strains of rats

1990 · J. Kaspareit-Rittinghausen, K. Wiese, et al. · Journal of Comparative Pathology · 8

A prospective and randomised clinical trial of the tyrosine kinase inhibitor imatinib mesylate as an initial therapy of advanced pancreatic cancer

2004 · M. Ebert, B. Nitsche, et al. · Journal of Clinical Oncology · 7

Works count: 7

Citation count: 91

H-index: 6

I10-index: 4